RxSight Statistics
NASDAQ: RXSTHealth CareOphthalmic GoodsUSD
4.72-0.085 (-1.77%)
Market open · Delayed 15 min · as of Oct 8, 11:54 AM ET
RxSight by the numbers
RxSight has a market capitalization of $196.1 million based on 41.59M shares outstanding. With trailing EPS of $-1.14, RxSight is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 20.6% below its 50-day average and 31.1% below its 200-day average.
Average daily trading volume is 861.57K shares, or about $4.1 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
RXST valuation vs. peer median
| Metric | RXST | Peer median | Difference |
|---|---|---|---|
| Market cap | $196.11M | $3.01B | -93% |
| Avg. volume | 861.57K | 2.15M | -60% |
Peer median across 7 companies: LUCY, STAA, EYE, WRBY, BLCO, COO, ALC.
Valuation
- Market cap
- $196.11M
- EPS (TTM)
- $-1.14
- Shares outstanding
- 41.59M
Price and trading
- Previous close
- 4.80
- Open
- 4.80
- Day range
- 4.68 – 4.80
- 52-week range
- 4.48 – 13.22
- 52-week change
- -42.03%
- Beta
- —
- Volume
- 213.78K
- Average volume
- 861.57K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 4, 2026
Additional statistics
- Market Cap
- 196.11M
- Forward Pe
- -6.77
- Eps
- -1.14
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 13.22
- Week52 Low
- 4.48
- Avg Volume
- 861.57K
- Shares Outstanding
- 41.59M
- Ma50
- 5.94
- Ma200
- 6.85
- Earnings Date
- Nov 4, 2026
- Pct From52w High
- -64.33%
- Pct From52w Low
- 5.25%